Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CASP3 | P42574 | 3/20 | 0.44 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
| ▸ | GRB2 | P62993 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3436122 | 0.91 | MDM4 (0.55) | MDM4TP53SLC17A5KMT2ACASP3 | |
| SCHEMBL29560536 | 0.91 | MDM4 (0.55) | MDM4TP53SLC17A5KMT2ACASP3 | |
| SCHEMBL29503847 | 0.91 | MDM4 (0.55) | MDM4TP53SLC17A5KMT2ACASP3 | |
| SCHEMBL29395463 | 0.91 | MDM4 (0.55) | MDM4TP53SLC17A5KMT2ACASP3 | |
| SCHEMBL1738641 | 0.91 | MDM4 (0.55) | MDM4TP53SLC17A5KMT2ACASP3 | |
| SCHEMBL5998507 | 0.91 | MDM4 (0.55) | MDM4TP53SLC17A5KMT2ACASP3 | |
| SCHEMBL29483556 | 0.88 | MDM4 (0.48) | MDM4TP53SLC17A5PTPN1KMT2A | |
| SCHEMBL29402146 | 0.86 | MDM4 (0.49) | MDM4TP53SLC17A5PTPN1KMT2A | |
| SCHEMBL8159150 | 0.86 | MDM4 (0.49) | MDM4TP53SLC17A5PTPN1KMT2A | |
| SCHEMBL29812711 | 0.86 | MDM4 (0.48) | MDM4TP53SLC17A5PTPN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114685614-B | Solid-phase synthesis method of atosiban | 湖北健翔生物制药有限公司 | 2024-07-12 | — | — | CN | claimed |
| WO-2022141615-A1 | SYNTHESIS METHOD FOR ATOSIBAN | 湖北健翔生物制药有限公司 | 2022-07-07 | — | — | WO | claimed |
| CN-114685614-B | Solid-phase synthesis method of atosiban | 湖北健翔生物制药有限公司 | 2024-07-12 | — | — | CN | disclosed |
| WO-2022141615-A1 | SYNTHESIS METHOD FOR ATOSIBAN | 湖北健翔生物制药有限公司 | 2022-07-07 | — | — | WO | disclosed |